Next Article in Journal
The Disease with a Thousand Faces and the Human Microbiome—A Physiopathogenic Intercorrelation in Pediatric Practice
Next Article in Special Issue
Biochemical, Nutritional, and Clinical Parameters of Vitamin B12 Deficiency in Infants: A Systematic Review and Analysis of 292 Cases Published between 1962 and 2022
Previous Article in Journal
Mediterranean Diet for Primary and Secondary Prevention of Cardiovascular Disease and Mortality: An Updated Systematic Review
 
 
Article
Peer-Review Record

Combined Newborn Screening Allows Comprehensive Identification also of Attenuated Phenotypes for Methylmalonic Acidurias and Homocystinuria

Nutrients 2023, 15(15), 3355; https://doi.org/10.3390/nu15153355
by Elena Schnabel 1, Stefan Kölker 1, Florian Gleich 1, Patrik Feyh 1, Friederike Hörster 1, Dorothea Haas 1, Junmin Fang-Hoffmann 1, Marina Morath 1, Gwendolyn Gramer 1,2, Wulf Röschinger 3, Sven F. Garbade 1, Georg F. Hoffmann 1, Jürgen G. Okun 1,† and Ulrike Mütze 1,*,†
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Nutrients 2023, 15(15), 3355; https://doi.org/10.3390/nu15153355
Submission received: 2 June 2023 / Revised: 18 July 2023 / Accepted: 21 July 2023 / Published: 28 July 2023
(This article belongs to the Special Issue The Role of Vitamin B12 in Maternal and Infant Health)

Round 1

Reviewer 1 Report

The manuscript "Combined Newborn Screening Allows Comprehensive Identification also of Attenuated Phenotypes for Methylmalonic Acidurias and Homocystinuria" addresses an important issue: evaluating the effectiveness and feasibility of newborn screening (NBS) for a range of metabolic disorders, including methylmalonic acidurias, propionic acidemia, homocystinuria, remethylation disorders, and neonatal vitamin B12 deficiency. The authors evaluated the NBS program's performance for the aforementioned disorders and report on the identification of cofactor-responsive disease variants.

The objectives were clearly stated and explained in the manuscript, however the experimental strategy raises some major concerns and so the experimental information from which the conclusions were drawn. The manuscript is overall well written and has good organization with minor English language and style spell check required. The authors have done a great job on analyzing the experimental data and on discussing the results and their limitations, considering always different alternative explanations/considerations for interpreting the results.

The paper is interesting but there is a need for more experimental detail in order to critically review the data. Specifically, they should provide information for the following questions and comments:

Major points:

1.      The authors should include more recent update on this topic and compare how this study further advances the current knowledge in the “Introduction section”.

2.      Unify the style of the references in the References Section and add DOI in the cases it is possible. And use the same reference and citation (follow MDPI’s guidelines) style in the main text.

3.      The Methods section in the study should be more accurately described for each technique used in the Materials & Methods Section.

4.      The Conclusion Section should be more thoroughly described.

Minor points:

1.      The resolution and quality of some Figures is low, the authors should provide higher quality Figures specially for Figure 1.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

You should be congratulated on a pilot involving over one half million newborns which clearly demonstrates that the multiple tier algorithm for C3 -related disorders is feasible and can detect cofactor-responsive disease, which much more often than not has been missed in more conventional screening programs.

While this reviewer would have appreciated seeing a comparison of your results to the pattern recognition that could have been achieved through CLIR (R4S collaborative project, Mayo Clinic), I appreciate that your algorithm and its implementation is essentially stand-alone and requires minimal additional technical personnel or data entry.  Such a comparison was not a goal of the NGS2025 study.

There are very few minor suggestions to the English language utilization as outlined below:

Line 108: Insert "to’ between prior and data

Line 356: Change “NBS on methylmalonic c” to “NBS of methylmalonic”

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

The authors have answered the proposed comments and suggestions and thus I recommend this article to be accepted.

Author Response

Thank you for your valuable advice.

Back to TopTop